Guillain-Barré syndrome in northwest Greece

S Markoula1, S Giannopoulos, I Sarmas

  • 1Department of Neurology, University of Ioannina, Medical School, Ioannina, Greece. me01415@cc.uoi.gr

Insights

Guillain-Barré syndrome (GBS) in Greece showed seasonal clustering in spring, with males more affected. Most patients experienced excellent recovery, though some had neurological sequelae, and no deaths were reported.

Area of Science:

  • Neurology
  • Epidemiology

Background:

  • Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting the peripheral nervous system.
  • Understanding the epidemiological and clinical features of GBS is crucial for public health management.

Purpose of the Study:

  • To describe the epidemiological and clinical-laboratory characteristics of Guillain-Barré syndrome (GBS) in northwest Greece.
  • To analyze incidence rates, patient demographics, clinical presentation, and outcomes over a 9.5-year period.

Main Methods:

  • Retrospective study of all GBS patients admitted to a neurology inpatient service from January 1996 to May 2005.
  • Comparison with previously published GBS case series.

Main Results:

  • Forty-six GBS patients were hospitalized; the average crude incidence rate was 1.22 per 100,000 population annually.
  • A significant spring seasonality was observed (52.17% of cases), with males being more susceptible.
  • The most common symptom was dysesthetic numbness; elevated liver function tests were noted in 56.52% of patients, resolving within weeks. Excellent recovery was common, with no deaths.

Conclusions:

  • GBS incidence and subtypes showed no significant change, but a distinct spring seasonality was confirmed.
  • Transient elevation of transaminases occurred in over half of the patients with an undetermined cause.
  • While 15.21% had significant neurological sequelae, the overall prognosis was favorable with no mortality.
Abstract

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...